120 related articles for article (PubMed ID: 33456770)
1. Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis.
Sharun K; Tiwari R; Dhama K
Ann Med Surg (Lond); 2021 Jan; 61():122-125. PubMed ID: 33456770
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
[TBL] [Abstract][Full Text] [Related]
3. Crystallization of Feline Coronavirus M
Lu J; Chen SA; Khan MB; Brassard R; Arutyunova E; Lamer T; Vuong W; Fischer C; Young HS; Vederas JC; Lemieux MJ
Front Chem; 2022; 10():852210. PubMed ID: 35281564
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
[TBL] [Abstract][Full Text] [Related]
5. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
[TBL] [Abstract][Full Text] [Related]
7. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
Izes AM; Yu J; Norris JM; Govendir M
Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses.
Perera KD; Galasiti Kankanamalage AC; Rathnayake AD; Honeyfield A; Groutas W; Chang KO; Kim Y
Antiviral Res; 2018 Dec; 160():79-86. PubMed ID: 30342822
[TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP.
Tseng YY; Liao GR; Lien A; Hsu WL
Comput Struct Biotechnol J; 2021; 19():1072-1080. PubMed ID: 33552444
[TBL] [Abstract][Full Text] [Related]
12. A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism.
Ho CY; Yu JX; Wang YC; Lin YC; Chiu YF; Gao JY; Lai SJ; Chen MJ; Huang WC; Tien N; Chen Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628479
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
[TBL] [Abstract][Full Text] [Related]
15. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features.
Haake C; Cook S; Pusterla N; Murphy B
Viruses; 2020 Sep; 12(9):. PubMed ID: 32933150
[TBL] [Abstract][Full Text] [Related]
17. Feline Coronavirus Antivirals: A Review.
Delaplace M; Huet H; Gambino A; Le Poder S
Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578182
[TBL] [Abstract][Full Text] [Related]
18. Better therapeutic effect of oral administration of GS441524 compared with GC376.
Yan Y; Li J; Jiao Z; Yang M; Li L; Wang G; Chen Y; Li M; Shen Z; Shi Y; Peng G
Vet Microbiol; 2023 Aug; 283():109781. PubMed ID: 37269714
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis.
Pedersen NC; Kim Y; Liu H; Galasiti Kankanamalage AC; Eckstrand C; Groutas WC; Bannasch M; Meadows JM; Chang KO
J Feline Med Surg; 2018 Apr; 20(4):378-392. PubMed ID: 28901812
[TBL] [Abstract][Full Text] [Related]
20. Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases.
Wang X; Xia S; Wang Q; Xu W; Li W; Lu L; Jiang S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
